[Federal Register Volume 88, Number 6 (Tuesday, January 10, 2023)]
[Notices]
[Pages 1389-1390]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-00290]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Advisory Council on Alzheimer's Research, Care, and Services; 
Meeting

AGENCY: Assistant Secretary for Planning and Evaluation, HHS.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: This notice announces the public meeting of the Advisory 
Council on Alzheimer's Research, Care, and Services (Advisory Council). 
The Advisory Council provides advice on how to prevent or reduce the 
burden of Alzheimer's disease and related dementias (ADRD) on people 
with the disease and their caregivers. During the meeting on January 30 
and 31, 2023, the Advisory Council will hear presentations on issues 
related to clinical practice and plans for advanced care planning. The 
second day presentations will review the impact of new drug approvals 
and focus on risk reduction and social determinants of health. The 
National Institute of Neurological Disorders and Stroke (NINDS) will 
present research milestones from the 2022 ADRD summit and other Federal 
agencies will also provide updates.

DATES: The meeting will be held virtually on January 30th from 12:30 
p.m. to 4:30 p.m. EST and January 31st from 12:30 p.m. to 4:30 p.m. 
EST.

ADDRESSES: The meeting will be virtual. It will stream live at 
www.hhs.gov/live.
    Comments: Time is allocated on the agenda to hear public comments 
from 4:00 p.m. to 4:30 p.m. on Tuesday January 31st. The time for oral 
comments will be limited to two (2) minutes per individual. In order to 
provide a public comment, please register by emailing your name to 
[email protected] by Thursday, January 26. Registered commenters will 
receive both a dial-in number and a link to join the meeting virtually; 
individuals will have the choice to either join virtually via the link, 
or to call in only by using the dial-in number. Note: There may be a 
30-45 second delay in the livestream video presentation of the 
conference. For this reason, if you have pre-registered to submit a 
public comment, it is

[[Page 1390]]

important to connect to the meeting by 3:45 p.m. to ensure that you do 
not miss your name and allotted time when called. If you miss your name 
and allotted time to speak, you may not be able to make your public 
comment. All participant audio lines will be muted for the duration of 
the meeting and only unmuted by the Host at the time of the 
participant's public comment. Should you have questions during the 
session email [email protected] and someone will respond to your message as 
quickly as possible.
    In order to ensure accuracy, please submit a written copy of oral 
comments for the record by emailing [email protected] by Wednesday, February 
1, 2023. These comments will be shared on the website and reflected in 
the meeting minutes.
    In lieu of oral comments, formal written comments may be submitted 
for the record by Wednesday, February 1, 2023 to Helen Lamont, Ph.D., 
OASPE, 200 Independence Avenue SW, Room 424E, Washington, DC 20201. 
Comments may also be sent to [email protected]. Those submitting written 
comments should identify themselves and any relevant organizational 
affiliations.

FOR FURTHER INFORMATION CONTACT: Helen Lamont, 202-260-6075, 
[email protected]. Note: The meeting will be available to the public 
live at www.hhs.gov/live.

SUPPLEMENTARY INFORMATION: Notice of these meetings is given under the 
Federal Advisory Committee Act (5 U.S.C. App. 2, section 10(a)(1) and 
(a)(2)). Topics of the Meeting: clinical care, dementia risk reduction, 
social determinants of health.
    Procedure and Agenda: The meeting will be webcast at www.hhs.gov/live and video recordings will be added to the National Alzheimer's 
Project Act website when available, after the meeting.
    Authority: 42 U.S.C. 11225; Section 2(e)(3) of the National 
Alzheimer's Project Act. The panel is governed by provisions of Public 
Law 92-463, as amended (5 U.S.C. Appendix 2), which sets forth 
standards for the formation and use of advisory committees.

    Dated: December 23, 2022.
Benjamin Sommers,
Senior Official Performing the Duties of the Assistant Secretary for 
Planning and Evaluation, Deputy Assistant Secretary for Health Policy.
[FR Doc. 2023-00290 Filed 1-9-23; 8:45 am]
BILLING CODE 4150-05-P